About Us

Biocodex at a glance

Present in more than 120 countries, Biocodex’s 1,626 employees are committed to serving millions of patients around the world. We apply our expertise to a wide range of products to meet patient needs, focusing on three pillars: the Microbiota Mission, orphan drugs and women’s health.

Biocodex key figures

  • An international pharmaceutical company serving patients in more than 120 countries
  • € 418M in revenue 2021
  • 3 pillars: the Microbiota Mission, orphan drugs and women’s health
  • Founded in 1953 to market Saccharomyces boulardii CNCM I-745®, the world’s first probiotic yeast strain for human medicine
  • More than 1,600 employees of 42 nationalities
  • 3 industrial facilities in France and Morocco
  • 1 R&D center in France
  • Subsidiaries in 20 countries
  • 114 distribution partners
  • An investor in 4 start-ups specialized in innovative health solutions

December 31, 2021 figures

Want to know more?

Young girl with long blond curly hair standing up and holding a globe baloon in a field background.
About Us

Our development

With global headquarters in France, Biocodex has expanded its geographic footprint over the past 10 years and today operates through 20 affiliates and long-term partnerships in other countries. Through this international network, Biocodex offers health solutions to patients in more than 120 countries.

View of Biocodex headquarters building in Gentilly, near Paris, France.
About Us

Our governance

Biocodex has two governing bodies: a Board of Directors and an Executive Committee. Jean-Marie Lefèvre is Chairman of the Board of Directors, while Nicolas Coudurier is our Chief Executive Officer.

Main entrance of Biocodex industrial facilities in Beauvais (Oise, France.
Our Science

Our facilities

Biocodex operates three manufacturing facilities in France and Morocco in compliance with the highest standards to guarantee product quality and safety.